Heart Test Laboratories-CW27HSCSWPreferred / convertible

13F holders, Q1 2025 (March 31)
3holders −2
0new positions
2sold out
1famous investor
$0.04avg. 13F price*

At the end of Q1 2025, 3 institutions reported holding Heart Test Laboratories-CW27 (HSCSW) in their 13F filings, down 2 from Q4 2024. 0 opened new positions and 2 sold out. The largest holders were Citadel Advisors ($11K), Clear Street LLC ($11K) and Susquehanna International Group, LLP ($1K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).

Company
Heart Test Laboratories-CW27
Filed as
HEARTSCIENCES INC (Q1 2025)
CUSIP
42254E112
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 5Q1 2024Q2 2024: 5Q2 2024Q3 2024: 3Q3 2024Q4 2024: 5Q4 2024Q1 2025: 3Q1 2025Q2 2025: 3Q2 2025Q3 2025: 3Q3 2025Q4 2025: 3Q4 2025Q1 2026: 3Q1 2026Q2 2026: 3Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions0$0
Exits2$151

All 13F filers, Q4 2024 → Q1 2025: 10,652 shares bought and 15,435 shares sold, net −4,783 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

Citadel Advisors — Add +5.0% 224,809 $11K
Clear Street LLC — No change 270,770 $11K
Susquehanna International Group, LLP — Reduce -25.7% 30,129 $1K

"% of holder's portfolio" is HSCSW's weight in each manager's 13F, not the share of Heart Test Laboratories-CW27 the manager owns.